Korro Bio · Cambridge, MA, US
· Posted 2026-10-28
· 1+ years
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
ResearchOligonucleotideChemistrykorrosynthesisoligonucleotidesgeneticmedicines
Korro Bio · Cambridge, MA, US
· Posted 2026-10-27
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
ContractsManagementclinicalagreementscontractcontractinglegalstudy
Korro Bio · Cambridge, MA, US
· Posted 2026-10-09
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
MedicalDirectorclinicalsafetydevelopmentreviewkorrogenetic
Korro Bio · Cambridge, MA, US
· Posted 2026-10-01
· 10+ years
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
DirectorClinicalQualityAssurancekorrononclinicalstudygclp
Korro Bio · Cambridge, MA, US
· Posted 2026-10-01
· 12+ years
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
ScientistHighThroughputScreeningkorroleadbiologydata
Korro Bio · Cambridge, MA, US
· Posted 2026-09-25
· 8+ years
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
DirectorDatamanagementclinicalstudykorroregulatoryprograms
Korro Bio · Cambridge, MA, US
· Posted 2026-09-15
· 8+ years
Korro is a biopharmaceutical company focused on developing a new class of genetic medicines for both rare and highly prevalent diseases using its proprietary RNA editing platform. Korro is generating a portfolio of differentiated programs that are designed to harness the body’s natural RNA editing process to effect a p
ClinicalTrialstudykorrostudiesoverseeglobalreview